Health-related quality of life is of great relevance for breast cancer patients at all stages, both during treatment and in the medium and long term after treatment. Quality of life is becoming increasingly important as an end point in licensing studies for new treatments and in scientific studies comparing different therapies. In addition to a brief global assessment of quality of life, other important patient-reported outcomes should be assessed. Patients with breast cancer often report limitations due to fatigue, sleep problems, sexual and/or climacteric problems, cognitive problems, mental problems and loss of physical performance. Quality of life after breast cancer could probably be further increased if education, screening and treatment of these symptoms were a systematic part of oncological care.